These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7835637)

  • 1. Further evidence that the tachycardiac response to 5-hydroxytryptamine in rats is not mediated via typical 5-HT2 receptors.
    Krstić MK; Katusić ZS
    Gen Pharmacol; 1994 Sep; 25(5):917-21. PubMed ID: 7835637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal cord serotonin receptors in cardiovascular regulation and potentiation of the pressor response to intrathecal substance P after serotonin depletion.
    Hasséssian H; Poulat P; Hamel E; Reader TA; Couture R
    Can J Physiol Pharmacol; 1993 Jul; 71(7):453-64. PubMed ID: 7694781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
    Maura G; Barzizza A; Folghera S; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor.
    Bom AH; Duncker DJ; Saxena PR; Verdouw PD
    Br J Pharmacol; 1988 Mar; 93(3):663-71. PubMed ID: 3370393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature of 5-HT1-like receptors mediating depressor responses in vagosympathectomized rats; close resemblance to the cloned 5-ht7 receptor.
    De Vries P; Villalón CM; Heiligers JP; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):90-9. PubMed ID: 9228195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors.
    Maura G; Roccatagliata E; Ulivi M; Raiteri M
    Eur J Pharmacol; 1988 Jan; 145(1):31-8. PubMed ID: 2965025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.
    Nishimura Y
    Br J Pharmacol; 1996 Mar; 117(6):1325-1333. PubMed ID: 8882632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
    García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
    Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
    Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological analysis of the cardiac effects of 5-HT and some 5-HT receptor agonists in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Fundam Clin Pharmacol; 1992; 6(6):237-45. PubMed ID: 1336759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord.
    Manuel NA; Wallis DI; Crick H
    Br J Pharmacol; 1995 Nov; 116(6):2647-54. PubMed ID: 8590984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery.
    Tadipatri S; van Heuven-Nolsen D; Feniuk W; Saxena PR
    Br J Pharmacol; 1991 Dec; 104(4):887-94. PubMed ID: 1667289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
    Anderson IK; Martin GR; Ramage AG
    Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
    Docherty JR
    J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular 5-HT1-like receptors that mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetized dogs are not of the 5-HT1A or 5-HT1D subtype.
    Perren MJ; Feniuk W; Humphrey PP
    Br J Pharmacol; 1991 Jan; 102(1):191-7. PubMed ID: 1675143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.